NDC 51662-1269

VERAPAMIL HCI

Verapamil Hci

VERAPAMIL HCI is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Hf Acquisition Co Llc, Dba Healthfirst. The primary component is Verapamil Hydrochloride.

Product ID51662-1269_76112f5f-ce5e-ec60-e053-2a91aa0aae4e
NDC51662-1269
Product TypeHuman Prescription Drug
Proprietary NameVERAPAMIL HCI
Generic NameVerapamil Hci
Dosage FormInjection, Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2018-09-17
Marketing CategoryANDA / ANDA
Application NumberANDA070737
Labeler NameHF Acquisition Co LLC, DBA HealthFirst
Substance NameVERAPAMIL HYDROCHLORIDE
Active Ingredient Strength3 mg/mL
Pharm ClassesP-Glycoprotein Inhibitors [MoA],Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 51662-1269-1

2 mL in 1 VIAL, SINGLE-DOSE (51662-1269-1)
Marketing Start Date2018-09-17
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 51662-1269-1 [51662126901]

VERAPAMIL HCI INJECTION, SOLUTION
Marketing CategoryANDA
Application NumberANDA070737
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-09-17
Inactivation Date2020-01-31
Reactivation Date2020-02-07

Drug Details

Active Ingredients

IngredientStrength
VERAPAMIL HYDROCHLORIDE2.5 mg/mL

OpenFDA Data

SPL SET ID:76112f5f-ce5d-ec60-e053-2a91aa0aae4e
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1665057
  • Pharmacological Class

    • P-Glycoprotein Inhibitors [MoA]
    • Calcium Channel Antagonists [MoA]
    • Calcium Channel Blocker [EPC]
    • Cytochrome P450 3A4 Inhibitors [MoA]
    • Cytochrome P450 3A Inhibitors [MoA]

    NDC Crossover Matching brand name "VERAPAMIL HCI" or generic name "Verapamil Hci"

    NDCBrand NameGeneric Name
    51662-1269VERAPAMIL HCIVERAPAMIL HCI
    51662-1442VERAPAMIL HCIVERAPAMIL HCI
    51662-1548VERAPAMIL HCIVERAPAMIL HCI

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.